HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Batteux, F. Articles by Chiocchia, G. Search for Related Content PubMed PubMed Citation Articles by Batteux, F. Articles by Chiocchia, G.

Gene Therapy of Experimental Autoimmune Thyroiditis by In Vivo Administration of Plasmid DNA Coding for Fas Ligand

Frédéric Batteux^*,, Léa Tourneur^*, Hélène Trebeden^*, Jeannine Charreire^* and Gilles Chiocchia^1,*

^* Institut National de la Santé et de la Recherche Médicale, Unité 477, Université René Descartes, Paris, France; and Laboratoire d’Immunologie, Faculté de Médecine Cochin-Port Royal, Université René Descartes, Paris, France

Fas-Fas ligand (FasL) interaction is required for the maintenance of immune homeostasis and seems to be responsible for the privileged immune status of some tissues. Experimental autoimmune thyroiditis (EAT), which is characterized by autoreactive T and B cell responses and a marked lymphocytic infiltration of the thyroid, is a model of choice to study the therapeutic effects of FasL. Here, we provide evidence that direct injection of DNA expression vectors encoding FasL into the inflamed thyroid inhibited development of lymphocytic infiltration of the thyroid and induced death of infiltrating T cells. These results were paralleled by a total abrogation of anti-Tg cytotoxic T cell response in FasL-treated animals vs controls. In summary, our results show that FasL expression on thyrocytes may have a curative effect on ongoing EAT by inducing death of pathogenic autoreactive infiltrating T lymphocytes.

This article has been cited by other articles:

				M. Nakahara, Y. Nagayama, O. Saitoh, R. Sogawa, S. Tone, and N. Abiru Expression of Immunoregulatory Molecules by Thyrocytes Protects Nonobese Diabetic-H2h4 Mice from Developing Autoimmune Thyroiditis Endocrinology, March 1, 2009; 150(3): 1545 - 1551. [Abstract] [Full Text] [PDF]

				S. H. Wang, J. D. Bretz, E. Phelps, E. Mezosi, P. L. Arscott, S. Utsugi, and J. R. Baker Jr. A Unique Combination of Inflammatory Cytokines Enhances Apoptosis of Thyroid Follicular Cells and Transforms Nondestructive to Destructive Thyroiditis in Experimental Autoimmune Thyroiditis J. Immunol., March 1, 2002; 168(5): 2470 - 2474. [Abstract] [Full Text] [PDF]

				J. Feldkamp, E. Pascher, M. Schott, P. Goretzki, J. Seissler, and W. A. Scherbaum Soluble Fas Is Increased in Hyperthyroidism Independent of the Underlying Thyroid Disease J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4250 - 4253. [Abstract] [Full Text] [PDF]

				J.-D. Lin The role of apoptosis in autoimmune thyroid disorders and thyroid cancer BMJ, June 23, 2001; 322(7301): 1525 - 1527. [Full Text] [PDF]

				H. Tang, K. Chen, Y. Wei, G. C. Sharp, L. McKee, and H. Braley-Mullen Apoptosis of thyrocytes and effector cells during induction and resolution of granulomatous experimental autoimmune thyroiditis Int. Immunol., December 1, 2000; 12(12): 1629 - 1639. [Abstract] [Full Text] [PDF]

				F. Batteux, P. Lores, D. Bucchini, and G. Chiocchia Transgenic Expression of Fas Ligand on Thyroid Follicular Cells Prevents Autoimmune Thyroiditis J. Immunol., February 15, 2000; 164(4): 1681 - 1688. [Abstract] [Full Text] [PDF]